ESTRO 2024 - Abstract Book

S2125

Clinical - Sarcoma, skin cancer, melanoma

ESTRO 2024

instills in us a growing sense of hope and pride in the daily work we undertake. It's important to note that the patients who receive radiotherapy in our study are those with complex and recurrent keloids, further underscoring the significance of our results.

Conclusion:

Keloid scars are notorious for their complex and challenging nature, primarily due to their high recurrence rates. The absence of a universally accepted optimal treatment strategy further complicates the management of this condition. Our study has shed light on a promising approach for keloid scar management. The combination of surgical excision with adjuvant RT emerged as an excellent treatment option. This approach yielded favorable results, as evaluated by both the patients and the clinicians involved in their care. It is worth noting that the patient and clinician perspectives regarding treatment outcomes may exhibit some variation, reflecting the nuanced nature of scar assessment. An encouraging aspect of our findings was the remarkably low recurrence rate observed in our study. However, it is important to acknowledge that the need for extended patient follow-up is essential to fully appreciate the long-term impact and sustainability of this treatment strategy.

Keywords: Radiotherapy, Keloid Scars

References:

1. Petrou IG, Jugun K, Ruegg EM, Zilli T, Modarressi A, Pittet-Cuenod B. Keloid treatment: what about adjuvant radiotherapy? Clin Cosmet Investig Dermatol. 2019;12:295-301

2. Noishiki C, Hayasaka Y, Ogawa R. Sex Differences in Keloidogenesis: An Analysis of 1659 Keloid Patients in Japan. Dermatol Ther (Heidelb). 2019;9(4):747-54.